Angiopro
Angiopro GmbH is a family-run German medical device distributor (founded 1999, Speyer) specializing in innovative cardiovascular devices and Health IT, selling B2B to hospitals and clinics across the DACH region and expanding into Benelux, the UK, and Scandinavia.
- Company typePrivate
- Founded1999
- HeadquartersSpeyer, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Angiopro does
Angiopro GmbH is a privately held, family-run medical device distribution and consulting company headquartered in Speyer, Germany. Founded in 1999 by CEO Hanns-Joachim Rieck, the firm operates as a classical distributor and importer under Article 2 No. 33 & 34 of the EU Medical Device Regulation (MDR), with a portfolio of innovative cardiovascular devices including structural heart implants (Nit-Occlud PFO occluder, DynamX Coronary Bioadaptor), coronary intervention devices (LithiX IVL balloon catheter), PTCA/PTA balloon dilatation catheters (Simvalve Force/Flex, the Simpass family), vascular stents (AndraStent Aortic XL/XXL), vascular rescue devices (AndraSnare), and inflation accessories. Angiopro also distributes a Health IT sub-portfolio (3mensio, CAAS, Ventripoint VMS+, Kinepict) targeted at cardiovascular imaging and procedure planning.
The company maintains ISO 9001:2015 certification and a pharmaceutical wholesale permit, and all of its employees are certified medical product consultants under § 31 MPG. Its end customers are hospitals, clinics, and specialists in cardiovascular and vascular medicine; its terms of business are restricted to entrepreneurs and public-law legal entities under § 14 of the German Civil Code (BGB), and the company sells exclusively through direct field sales and exclusive distribution agreements, with no public pricing.
Angiopro's go-to-market is exclusively B2B and channel-based. Beyond its long-standing German DACH distribution footprint, the firm has in 2025-2026 expanded its European reach through a letter of intent with Profusa Inc. to commercialize the Lumee Oxygen platform across Germany, Benelux, Austria, the United Kingdom, and Scandinavia (together covering roughly 35% of the EU population), and through a Germany distribution partnership with Ventripoint Diagnostics for the VMS+ cardiac imaging technology. A complementary distribution partnership with Dismeval extends Profusa's coverage into roughly 35% of the European critical limb-threatening ischemia procedure market. The company is family-controlled by Hanns-Joachim Rieck and Benjamin Rieck, with no disclosed external institutional investment, venture capital, or private equity backing.
Angiopro firmographics
Firmographics- Name
- Angiopro
- Legal name
- Angiopro GmbH
- Website
- https://angiopro.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Angiopro GmbH is a family-run German medical device distributor (founded 1999, Speyer) specializing in innovative cardiovascular devices and Health IT, selling B2B to hospitals and clinics across the DACH region and expanding into Benelux, the UK, and Scandinavia.
- Ownership category
- akta.pro rank
Angiopro industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
- akta.pro secondary industries
- Coronary Stents & Drug-Eluting Technologies (HLAHAFAA), Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB), Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
Keywords
Where Angiopro is headquartered
LocationHeadquarters
- HQ city
- Speyer
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Angiopro business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Distribution: Distribution and sales of innovative cardiovascular medical devices and products. Revenue generated through product sales as a distributor and importer operating under MDR Article 2 No. 33 & 34.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels3 records
Angiopro product offering
Product offeringCore offering
Angiopro GmbH is a family-run classical distributor and importer of innovative cardiovascular and vascular medical devices, operating under MDR Article 2 No. 33 & 34. The company distributes a portfolio of branded devices including structural heart implants (Nit-Occlud PFO, DynamX Bioadaptor), coronary intervention devices (LithiX IVL), PTCA/PTA balloon catheters, stents, and inflation syringes to hospitals and clinics across Germany and the broader European region.
Product overview
Angiopro is a cardiovascular medical device distributor and importer specializing in innovative products and technologies in vascular medicine. The company does not offer a unified software platform but rather distributes a portfolio of branded medical devices including: structural heart implants (Nit-Occlud® PFO occluder, DynamX Bioadaptor), coronary intervention devices (LithiX IVL balloon catheter), PTCA/PTA balloon dilatation catheters (Simvalve Force/Flex, Simpass series), vascular stents (AndraStent Aortic XL/XXL), vascular rescue devices (AndraSnare), inflation syringes (Flamingo, Dolphin), and peripheral intervention balloons (AndraBalloon, Andra2Balloon, Apexus). Products are sourced from international manufacturers and distributed across Germany and the D-A-CH region.
Differentiator
Problem solved
Functional benefit
Products and services
- Nit-Occlud PFO Nitinol occluder specifically developed for closure of the congenital heart defect PFO (Patent Foramen Ovale). Features a special umbrella design with right atrial double disc and left atrial single disc, with reduced nitinol content in the LA to reduce thrombo-embolic risk. Used by interventional cardiologists in congenital and structural heart procedures.
- DynamX Coronary Bioadaptor System Next-generation coronary implant with partially bioresorbable polymer technology that allows natural expansion and movement of the artery while reducing restenosis risk. Targeted at interventional cardiologists performing coronary interventions.
- LithiX IVL Balloon Catheter Coronary intravascular lithotripsy (IVL) balloon catheter that precisely fractures calcium without damaging soft tissue, providing gentle treatment of calcified coronary arteries without external energy source and reducing risk of dissections and perforations.
- Simvalve Force PTV Balloon Dilatation Catheter PTV (Over-the-Wire) balloon dilatation catheter used in cardiovascular interventions.
- Simvalve Flex PTV Balloon Dilatation Catheter Flexible PTV balloon dilatation catheter featuring short and soft catheter tip for safe cardiovascular procedures.
- AndraStent Aortic XL and XXL Largest stent available on the market for coarctation of the aorta. XL: 7 Fr to 13 Fr introducer sheaths, 8 to 25 mm diameter, 13 to 57 mm length. XXL: 10 Fr to 14 Fr, 12 to 32 mm diameter, 21 to 57 mm length. MR Conditional certified.
- AndraSnare Flexible snare for interventional retrieval of foreign bodies from vessels. Features atraumatic and gold-coated nitinol loop for optimal visibility and preformed tip for better control.
- Flamingo Inflation Syringe Compact and ergonomic inflation syringe with manometer showing pressure up to 30 atm, rotatable up to 90 degrees, featuring progressive resistance during inflation and easy handling through ergonomic design.
- Dolphin Inflation Syringe Inflation syringe compatible with all balloon catheters. Features T-handle for comfortable rotation and easy air release, automatic closing system, and manometer showing pressure up to 30 atm.
- Simpass NC/HP Non-Compliant High Pressure PTCA balloon with durable and tear-resistant material, kink-resistant hypotube, and minimal longitudinal balloon growth.
- Simpass Plus Semi-Compliant PTCA balloon with excellent pushability and kink resistance.
- Simpass CTO Chronic Total Occlusion PTCA balloon with exclusive tip design and low entry profile.
- Simpass Endo 14 0.014 inch RX PTA balloon with easy crossing through improved pushability and flat profile.
- Simpass Endo 18 0.018 inch OTW PTA balloon with long balloon options and multiple inflation capability.
- Simpass Endo 35 0.035 inch OTW PTA balloon with flat entry and balloon profile, large deflation lumen, and hydrophilic coating.
- AndraBalloon PTA catheter with rapid inflation and deflation and wide range of sizes for peripheral vascular procedures.
- Andra2Balloon PTA catheter optimized for stent dilation with coaxial shaft design for rapid inflation and deflation and 2 Pt/Ir X-ray markers on inner shaft.
Companies that use Angiopro
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Angiopro technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Angiopro partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Ventripoint DiagnosticscoreAngiopro serves as Ventripoint Diagnostics' distribution partner in Germany for the VMS+ cardiac imaging technology. The company is building distribution partnerships across Germany, China, and exploring opportunities in India and Brazil. Revenue from this partnership is expected to begin accruing in Q2 2026.
- Lishman Global Inc.coreVentripoint Diagnostics is building distribution partnerships with Lishman Global for the China market as part of its global distribution strategy alongside Angiopro in Germany.
- DismevalminorEuropean distribution partnership with Dismeval covering 35% of the European critical limb-threatening ischemia procedure market, complementing the Angiopro partnership for Profusa's Lumee Oxygen platform.
- Profusa Inc.coreAngiopro GmbH signed a letter of intent with Profusa Inc. to establish European logistics and commercialization infrastructure for its Lumee Oxygen platform. The partnership targets EU market entry in Q2 2026 and U.S. entry in early 2027, with coverage of approximately 35% of the European Union population including Germany, Benelux, Austria, UK, and Scandinavia.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Angiopro competitors and assessment
Company assessmentBroad incumbents
- Penumbra Inc. US-based vascular thrombectomy and embolization device manufacturer with EU distribution - competes in adjacent interventional vascular categories Angiopro covers and engages similar cardiovascular call points in EU hospitals.
- BIOTRONIK: Leading German manufacturer of pacemakers, ICDs, stents, and vascular intervention devices with deep cardiovascular hospital relationships in DACH - comparable to Angiopro in cardiovascular category and DACH market, but BIOTRONIK is the OEM rather than a distributor.
- Maquet / Getinge Vascular Systems: European cardiovascular and vascular surgery systems manufacturer with strong DACH presence - directly comparable in delivering devices used in cardiac and vascular surgery operating rooms and cath labs where Angiopro's call points sit.
- Teleflex / Vascular Solutions: Global interventional cardiology and vascular access device manufacturer (acquired Vascular Solutions) - directly comparable in coronary and peripheral intervention device categories distributed by Angiopro and in European cardiovascular hospital channel access.
- Abbott Vascular (Abbott): Global cardiovascular device manufacturer covering coronary (Xience stents, Dragonfly IVL), structural heart, and endovascular categories - directly competes with the same product categories Angiopro distributes (coronary stents, IVL, PFO occluders) and has European direct sales forces overlapping Angiopro's target hospitals.
- Asahi Intecc: Japanese manufacturer and European distributor of guidewires, catheters, and peripheral/coronary intervention devices with strong DACH sales presence via Asahi Intecc Deutschland - comparable portfolio overlap with Angiopro's PTA/PTCA and vascular access products, but operates as OEM.
Direct peers
- Inspira Med GmbH: Austrian/German specialty distributor of innovative interventional cardiology and radiology devices serving DACH hospitals - directly comparable niche position as a German-language specialty cardiovascular distributor working via OEM partnerships.
- Medi-Globe Group: German-based specialty medical device developer and distributor focused on minimally invasive therapies, serving interventionalists across Europe - directly comparable in being a German-rooted specialty distributor serving cardiovascular and endoscopy interventional cardiology call points.
- AndraTec (Andramed / Andratec): German specialty medical device company focused on innovative cardiovascular products (AndraStent, AndraSnare, AndraBalloon - the very brand family Angiopro distributes) - the upstream OEM and direct comparable in product niche and German cardiovascular specialty sales model.
Regional players
- Balt Extrusion: European specialty manufacturer and distributor of neurovascular and peripheral vascular intervention devices with overlapping EU geographies - comparable product focus on catheter-based vascular intervention distributed through specialty channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Angiopro social profiles
Digital presenceAngiopro compliance and trust
Trust signalCompliance1 record
Angiopro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Angiopro leadership team
Management profileNumber of profiles
Profiles2 records
Angiopro funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Angiopro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Angiopro
What does Angiopro do?
Angiopro GmbH is a family-run classical distributor and importer of innovative cardiovascular and vascular medical devices, operating under MDR Article 2 No. 33 & 34. The company distributes a portfolio of branded devices including structural heart implants (Nit-Occlud PFO, DynamX Bioadaptor), coronary intervention devices (LithiX IVL), PTCA/PTA balloon catheters, stents, and inflation syringes to hospitals and clinics across Germany and the broader European region.
Is Angiopro a public or private company?
Angiopro is a private company. It is classified as family owned and is currently operating.
When was Angiopro founded?
Angiopro was founded in 1999. It employs 1 to 10 people.
Where is Angiopro based?
Angiopro is headquartered in Speyer, Germany, in the Europe region.
How does Angiopro make money?
One revenue line is on record: medical Device Distribution.
Who are Angiopro's main competitors?
Broad incumbents on record are Penumbra Inc., BIOTRONIK, Maquet / Getinge Vascular Systems, Teleflex / Vascular Solutions, Abbott Vascular (Abbott) and Asahi Intecc. Direct peers are Inspira Med GmbH, Medi-Globe Group and AndraTec (Andramed / Andratec). Balt Extrusion is listed as a regional player.
Does Angiopro have an API?
No public API is recorded for Angiopro.
What industry is Angiopro in?
Angiopro's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAKABAB, Interventional Cardiology (PCI/Structural Heart), with a secondary code of HLAHAFAA, Coronary Stents & Drug-Eluting Technologies. Its NAICS code is 3391 and its SIC code is 5047.